Pneumonia Panel by PCR

Also known as: PFAP

Clinical Use

Use

The Pneumonia Panel by PCR aids in the diagnosis of bacterial and viral pneumonia from lower respiratory tract specimens. It is specifically designed for use in individuals exhibiting clinically compatible signs and symptoms of pneumonia. The panel targets the detection of the most common bacterial and viral causes of pneumonia, facilitating timely diagnosis and appropriate treatment. By employing PCR methodology, the panel provides rapid results and helps differentiate between bacterial and viral infections, which is essential for tailoring effective treatment strategies and avoiding unnecessary antibiotic usage.

Special Instructions

Not provided.

Limitations

The pneumonia panel is not intended to replace traditional respiratory, blood, or urine antigen cultures. It detects only the most common pneumonia pathogens, meaning less prevalent or fungal pathogens may not be identified. The PCR results do not directly correlate with bacterial culture results as the PCR method may not report bacteria present in very low quantities due to applied algorithm thresholds. Additionally, the panel does not detect SARS-CoV-2 (COVID-19). Therefore, comprehensive testing including traditional culture methods alongside the panel is recommended for a thorough analysis.

Test Details

New York Approved

Methodology

PCR-based (PCR)

Biomarkers

33 targets

Acinetobacter baumannii complexAdenovirusChlamydia pneumoniaeCoronavirusCTX-MEnterobacter cloacae complexEscherichia coliHaemophilus influenzae+25 more

LOINC Codes

Result Codes

92989-3 - Acb cmplx DNA BAL NAA+non-prb-NCncRng
94379-5 - E cloac comp DNA Lower resp Ql NAA+probe
94378-7 - E coli DNA Lower resp Ql NAA+probe
94377-9 - Haem influ DNA Lower resp Ql NAA+probe
94376-1 - K. aerogenes DNA Lower resp Ql NAA+probe
94375-3 - K oxytoca DNA Lower resp Ql NAA+probe
94374-6 - K pnm DNA Lower resp Ql NAA+probe
94373-8 - M catarrhalis DNA Lower Resp Ql NAA+prb
94372-0 - Proteus sp DNA Lower resp Ql NAA+probe
94371-2 - P aerugns DNA Lower resp Ql NAA+probe
94370-4 - S marcscns DNA Lower resp Ql NAA+probe
94369-6 - S aureus DNA Lower resp Ql NAA+probe
94368-8 - Gp B Strep DNA Lower resp Ql NAA+probe
94367-0 - S pneum DNA Lower resp Ql NAA+probe
94366-2 - S pyo DNA Lower resp Ql NAA+probe
92986-9 - C pneum DNA Lower resp Ql NAA+n-prb
92969-5 - L pneumo DNA Lower resp Ql NAA+n-prb
92964-6 - M pneumo DNA Lower resp Ql NAA+n-prb
92987-7 - HAdV DNA Lower resp Ql NAA+n-prb
92979-4 - HCoV RNA Lower resp Ql NAA+n-prb
92978-6 - hMPV RNA Lower resp Ql NAA+n-prb
92956-2 - RV+EV RNA Lower resp Ql NAA+n-prb
92977-8 - FLUAV RNA Lower resp Ql NAA+n-prb
92976-0 - FLUBV RNA Lower resp Ql NAA+n-prb
92963-8 - HPIV RNA Lower resp Ql NAA+n-prb
92957-0 - RSV RNA Lower resp Ql NAA+n-prb
85498-4 - blaIMP Islt/Spm Ql
49617-4 - blaKPC Islt/Spm Ql
73982-1 - blaNDM Islt/Spm Ql
85827-4 - blaOXA-48-like Islt/Spm Ql
85501-5 - blaVIM Islt/Spm Ql
88250-6 - blaCTX-M Islt/Spm Ql
96309-0 - mecA+mecC+MREJ Islt/Spm Ql

Result Turnaround Time

1 day

Specimen

Bronchoalveolar Lavage

Volume

1.0 mL

Minimum Volume

0.5 mL

Container

sterile container

Collection Instructions

Transfer specimen to a sterile container. Specimens should not be centrifuged, preprocessed, treated with mucolytic or decontaminating agents, or placed into transport media before testing.